Supplemental Oxygen in Pulmonary Embolism (SO-PE)

Recruiting now · Early Phase 1

Conditions studied: Pulmonary Embolism, Venous Thromboembolism, Metabolomics, Oxygen Inhalation Therapy

In brief

A study of how supplemental oxygen helps patients with acute pulmonary embolism (PE). Hypothesis: Oxygen affects right ventricular dysfunction (RVD) in patients with acute pulmonary embolism (PE) primarily by relieving hypoxic pulmonary vasoconstriction and reducing pulmonary pressure (PA) pressure, and that this process is metabolically driven.

Key facts

Study ID
NCT05891886
Run by
Massachusetts General Hospital
People needed
80
Starts
2023-10-01
Expected to finish
2027-06-30
Last updated by the study team
2025-06-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.